These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36316285)

  • 1. Owner preference for insulin delivery device and glycaemic control in diabetic dogs.
    Del Baldo F; Colajanni L; Corradini S; Palagiano P; Di Cunzolo A; Perissinotto L; Drudi I; Horspool L; Fracassi F
    J Small Anim Pract; 2023 Apr; 64(4):255-264. PubMed ID: 36316285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy and precision of insulin administration using human and veterinary pen-injectors and syringes for administration of insulin.
    Malerba E; Fracassi F; Del Baldo F; Golinelli S; Ceccherini M; Barbarossa A
    J Vet Intern Med; 2021 May; 35(3):1255-1264. PubMed ID: 33991138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of the impact of periodontal treatment on markers of glycaemic control in dogs with diabetes mellitus: A prospective, clinical case series.
    Nivy R; Bar-Am Y; Retzkin H; Bruchim Y; Mazaki-Tovi M
    Vet Rec; 2024 Jan; 194(1):e3310. PubMed ID: 37608628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of type of starch and feeding management on glycaemic control in diabetic dogs.
    Teshima E; Brunetto MA; Teixeira FA; Gomes MOS; Lucas SRR; Pereira GT; Carciofi AC
    J Anim Physiol Anim Nutr (Berl); 2021 Nov; 105(6):1192-1202. PubMed ID: 33904623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of diabetes mellitus in dogs using isophane insulin penfills and the use of serum fructosamine assays to diagnose and monitor the disease.
    Thoresen SI; Lorenzen FH
    Acta Vet Scand; 1997; 38(2):137-46. PubMed ID: 9257449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of lente insulin and NPH insulin therapy for the treatment of newly diagnosed diabetic dogs: a randomised study.
    Fracassi F; Linari G; Del Baldo F; Di Cunzolo A; D'Angelo S; Malerba E; Carotenuto G; Bonfanti U; Corradini S
    Vet Rec; 2018 Sep; 183(8):262. PubMed ID: 30030413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients.
    Dunbar JM; Madden PM; Gleeson DT; Fiad TM; McKenna TJ
    Diabetes Care; 1994 Aug; 17(8):874-8. PubMed ID: 7956634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the alpha-glucosidase inhibitor acarbose on control of glycemia in dogs with naturally acquired diabetes mellitus.
    Nelson RW; Robertson J; Feldman EC; Briggs C
    J Am Vet Med Assoc; 2000 Apr; 216(8):1265-9. PubMed ID: 10767967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fructosamine concentration as an index marker for glycaemic control in diabetic dogs.
    Zeugswetter FK; Beer R; Schwendenwein I
    Vet Rec; 2022 Jan; 190(2):e244. PubMed ID: 33870504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study.
    Bohannon N; Bergenstal R; Cuddihy R; Kruger D; List S; Massaro E; Molitch M; Raskin P; Remtema H; Strowig S; Whitehouse F; Brunelle RL; Dreon D; Tan M
    Diabetes Technol Ther; 2011 Oct; 13(10):1031-7. PubMed ID: 21732797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field efficacy and safety of protamine zinc recombinant human insulin in 276 dogs with diabetes mellitus.
    Ward CR; Christiansen K; Li J; Bryson WL; Jerrentrup KA; Kroh C
    Domest Anim Endocrinol; 2021 Apr; 75():106575. PubMed ID: 33186842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of insulin glargine in dogs with diabetes mellitus.
    Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
    Vet Rec; 2012 Jan; 170(2):52. PubMed ID: 22008227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes.
    Seggelke SA; Hawkins RM; Gibbs J; Rasouli N; Wang CC; Draznin B
    Endocr Pract; 2014 Jun; 20(6):536-9. PubMed ID: 24326004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory analysis of anti-insulin antibodies in diabetic dogs receiving recombinant human insulin.
    Lester M; O'Kell AL
    J Small Anim Pract; 2020 Apr; 61(4):236-240. PubMed ID: 32012274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between HbA1c, fructosamine and clinical assessment of glycemic control in dogs.
    Norris O; Schermerhorn T
    PLoS One; 2022; 17(2):e0264275. PubMed ID: 35213623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Owner experiences in treating dogs and cats diagnosed with diabetes mellitus in the United States.
    Aptekmann KP; Armstrong J; Coradini M; Rand J
    J Am Anim Hosp Assoc; 2014; 50(4):247-53. PubMed ID: 24855090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.